SHELTON, CT / ACCESS Newswire / May 18, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical ...
The increasing diversity of viral pathogens that cause emerging and re-emerging infectious diseases is a challenge for developing broad-spectrum antivirals. The development of specific antivirals ...
Clinical outcomes among adult inpatients were no worse when broad-spectrum antibiotic therapy was delayed vs started early, challenging the belief that overly broad-spectrum empiric antibiotic therapy ...
Please provide your email address to receive an email when new articles are posted on . “Pediatric practice guidelines for the diagnosis and management of initial UTI in febrile infants and young ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results